专题：Cancer Diagnosis and Treatment

This cluster of papers focuses on the diagnosis, treatment, and molecular characterization of Cancer of Unknown Primary (CUP) site. It includes research on metastatic patterns, molecular profiling to identify tissue of origin, immunohistochemical markers, diagnostic algorithms, and clinical management strategies.
最新文献
SPARC Induces COL1A1/COL3A1 Expressions Representing Aggressive Molecular Cancer-Associated Fibroblasts Signatures and CSF1-Mediated Cancer Invasion in Colorectal Cancer

article Full Text OpenAlex

Complete Response to Nivolumab and Ipilimumab After Pazopanib Discontinuation in a Seven‐Year‐Old Girl With Alveolar Soft Part Sarcoma: A Case Report and Literature Review

review Full Text OpenAlex

Benigne Knochentumoren und tumorähnliche Läsionen (Teil 1)

article Full Text OpenAlex

OncoTrace‐TOO: Interpretable Machine Learning Framework for Cancer Tissue‐of‐Origin Identification Using Transcriptomic Signatures

article Full Text OpenAlex

Oncological Outcomes, Survival Analysis, and Failure Patterns in Patients with Resectable Squamous Cell Carcinoma of the Oral Tongue Treated with Glossectomy

article Full Text OpenAlex

Clinical and pathological features of early-stage metaplastic carcinoma and associated patient outcomes.

article Full Text OpenAlex

Tolerability and safety of a new oral device for prevention and treatment of oral mucositis in patients with hematologic malignancies undergoing chemotherapy

article Full Text OpenAlex

Adverse Prognosis in Dialysis Patients Undergoing Systemic Therapy for Metastatic Renal Cell Carcinoma: A Retrospective Study

article Full Text OpenAlex

Interstitial lung disease induced by Toripalimab combined with disitamab Vedotin in upper tract urothelial carcinoma: a case report and literature review

article Full Text OpenAlex

Cancer of Unknown Primary Site and TNM Staging: A New Paradigm for Patient Management

review Full Text OpenAlex

近5年高被引文献
American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update

review Full Text OpenAlex 752 FWCI31.339

Head and neck cancer

review Full Text OpenAlex 303 FWCI33.067

Metastasis to thyroid gland

reference-entry Full Text OpenAlex 298 FWCI0

AI-based pathology predicts origins for cancers of unknown primary

article Full Text OpenAlex 239 FWCI41.401

A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1.

article Full Text OpenAlex 210 FWCI58.201

Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study

article Full Text OpenAlex 186 FWCI26.873

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

review Full Text OpenAlex 184 FWCI6.084

Novel approaches to target the microenvironment of bone metastasis

review Full Text OpenAlex 156 FWCI4.863

Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial

article Full Text OpenAlex 154 FWCI6.151

Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial

article Full Text OpenAlex 152 FWCI41.295